Anti-C4B-d / C4B-b antibody [EPR11203-27]
- BOND RX™ Validated
- RabMAb
- Recombinant
- 20ul selling size
- What is this?
2
(1 Review)
|
(6 Publications)
Rabbit Recombinant Monoclonal C4B-d / C4B-b antibody. Suitable for ICC/IF, WB, IHC-P and reacts with Human samples. Cited in 5 publications.
View Alternative Names
CO4, CPAMD3, C4B_2, C4B, Complement C4-B, Basic complement C4, C3 and PZP-like alpha-2-macroglobulin domain-containing protein 3
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-C4B-d / C4B-b antibody [EPR11203-27] (AB181241)
Immunocytochemistry/ Immunofluorescence analysis of HepG2 (Human hepatocellular carcinoma epithelial cell) cells labeling C4b with purified ab181241 at 1/100 dilution (10 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% TritonX-100. Cells were counterstained with ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594) 1/200 (2.5 μg/ml). Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C4B-d / C4B-b antibody [EPR11203-27] (AB181241)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human liver tissue sections labeling C4b with purified ab181241 at 1/75 dilution (9.53 µg/mL). Heat mediated antigen retrieval using Bond™ Epitope Retrieval Solution 2 (pH 9.0) . Rabbit specific IHC polymer detection kit HRP/DAB (ab209101) was used as the secondary antibody. Negative control : PBS instead of the primary antibody. Hematoxylin was used as a counterstain.
- WB
Unknown
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (AB181241)
The molecular weights observed are consistent with what have been described in the literature (PMID : 15632414, 31178241 and 30210498).
All lanes:
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (ab181241) at 1/10000 dilution
Lane 1:
HepG2 (Human hepatocellular carcinoma epithelial cell) whole cell lysate at 15 µg
Lane 2:
Human plasma lysate at 15 µg
Lane 3:
Human serum lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 193 kDa
Observed band size: 200 kDa,70 kDa,93 kDa
false
- WB
Lab
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (AB181241)
Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lanes 1 - 5:
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (ab181241) at 1/1000 dilution
Lanes 6 - 10:
Western blot - Anti-6X His tag® antibody [EPR20547] - ChIP Grade (<a href='/en-us/products/primary-antibodies/6x-his-tag-antibody-epr20547-chip-grade-ab213204'>ab213204</a>) at 1/5000 dilution
Lanes 1 and 6:
293T cells transfected with an empty vector containing a His tag whole cell lysate at 20 µg
Lanes 2 and 7:
293T cells transfected with a human C4d-A (Uniprot: P0C0L4 aa957-1336) expression vector containing a His-tag whole cell lysate at 20 µg
Lanes 3 and 8:
293T cells transfected with a human C4d-B (Uniprot: P0C0L5 aa957-1336) expression vector containing a His-tag whole cell lysate at 20 µg
Lanes 4 and 9:
293T cells transfected with a human C4-A alpha chain (Uniprot: P0C0L4 aa680- 1446) expression vector containing a His-tag whole cell lysate at 20 µg
Lanes 5 and 10:
293T cells transfected with a human C4b-A (Uniprot: P0C0L4 aa757-1446) expression vector containing a His-tag whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 45-100 kDa
false
Exposure time: 1s
- WB
Unknown
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (AB181241)
The molecular weights observed are consistent with what have been described in the literature (PMID : 15632414, 31178241 and 30210498).
All lanes:
Western blot - Anti-C4B-d / C4B-b antibody [EPR11203-27] (ab181241) at 1/10000 dilution
Lane 1:
Human liver lysate at 20 µg
Lane 2:
Human heart lysate at 20 µg
Lane 3:
Human testis lysate at 20 µg
Secondary
All lanes:
Goat Anti-Rabbit IgG (HRP) with minimal cross-reactivity with human IgG at 1/2000 dilution
Predicted band size: 193 kDa
Observed band size: 200 kDa,70 kDa,93 kDa
false
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The 'C4b complement' interacts with various other components of the immune system. It is particularly involved in the formation of the C3 and C5 convertase complexes which are essential for the opsonization and activation cascade leading to pathogen elimination. Its attachment to cellular surfaces provides a docking point for proteins such as C2 facilitating the further cleavage and progression of the complement cascade. This interaction is critical for driving the classical and lectin pathways of complement activation.
Pathways
The 'C4b protein' is integral to the classical pathway of complement activation as well as to the lectin pathway. It associates with proteins like C1s C1q and factor B forming complexes that execute various stages of immune defenses. By forming C3 and C5 convertase 'C4b' not only promotes phagocytosis but also inflammation and cell lysis through membrane attack complexes. These processes underlie the body's ability to address microbial invasions efficiently.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (6)
Recent publications for all applications. Explore the full list and refine your search
Journal of virology 99:e0180424 PubMed39846741
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of clinical periodontology 50:657-670 PubMed36632003
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 14:473 PubMed36709213
2023
Applications
Unspecified application
Species
Unspecified reactive species
Neuron 105:975-991.e7 PubMed31926610
2020
Applications
Unspecified application
Species
Unspecified reactive species
Cell host & microbe 25:617-629.e7 PubMed30926239
2019
Applications
Unspecified application
Species
Unspecified reactive species
Experimental eye research 172:21-29 PubMed29580721
2018
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com